Skip to main content
. 2020 Aug 27;9(17):e017039. doi: 10.1161/JAHA.120.017039

Table 1.

Baseline Characteristics of Study Population at MESA Exam 1 by APOL1 Risk Status

Characteristic All (n=1619) APOL1 high‐risk (n=190) APOL1 low‐risk (n=1429)
Age, y 62±10 62±9 62±10
Female 876 (54) 96 (51) 780 (55)
Education
Less than high school 180 (11) 25 (13) 155 (11)
High school graduate 312 (19) 32 (17) 280 (20)
Postsecondary 1116 (69) 132 (70) 984 (69)
Employment
Employed 658 (41) 76 (40) 582 (41)
Unemployed/employed part‐time 125 (8) 18 (10) 107 (8)
Retired/homemaker 824 (51) 95 (50) 729 (51)
Annual family income
<$25 000 437 (29) 49 (28) 388 (29)
$25 000–$49 999 486 (33) 57 (33) 429 (32)
$50 000–$74 999 310 (21) 35 (20) 275 (21)
≥$75 000 263 (18) 32 (19) 231 (18)
Smoking status
Never 738 (46) 84 (44) 654 (46)
Former 579 (36) 67 (35) 512 (36)
Current 291 (18) 38 (20) 253 (18)
Diabetes mellitus 274 (17) 40 (21) 234 (16)
Fasting glucose, mg/dL 100±32 102±32 100±32
Hypertension 946 (58) 119 (63) 827 (58)
Systolic BP, mm Hg 131±21 132±21 131±21
Diastolic BP, mm Hg 75±10 74±10 75±10
Pulse pressure, mm Hg 57±17 58±18 57±17
Antihypertensive medication use 802 (50) 104 (55) 698 (49)
Total cholesterol, mg/dL 190±36 190±37 190±36
Triglycerides, mg/dL 89 [66–122] 88 [65–122] 89 [66–122]
HDL, mg/dL 52±15 54±16 52±15
LDL, mg/dL 117±33 116±35 117±33
Lipid‐lowering medication use 253 (16) 33 (17) 220 (15)
Body mass index, kg/m2 30.1±5.8 30.1±6.0 30.1±5.7
Moderate‐vigorous PA, MET‐min/wk 4613 [2160–8588] 4455 [2135–8370] 4636 [2160–8678]
Family history of heart disease 634 (42) 63 (35) 571 (43)
eGFRCysC, mL/min/1.73 m2 90±20 90±19 90±20
UACR, mg/g 5.3 [3.1–12.0] 5.5 [3.3–14.5] 5.2 [3.0–11.9]
UACR ≥30 170 (11) 27 (14) 143 (10)

Values presented as mean±SD, median [interquartile range], or number (percentage). BP, blood pressure; eGFRCysC, estimated glomerular filtration rate based on cystatin C; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; MESA, Multi‐Ethnic Study of Atherosclerosis; MET, metabolic equivalent; PA, physical activity; and UACR, urine albumin‐to‐creatinine ratio.